Zobrazeno 1 - 10
of 66
pro vyhledávání: '"HBV therapy"'
Autor:
Zhan Zeng, Hongxiao Hao, Xiaoyue Bi, Yanjie Lin, Liu Yang, Shiyu Wang, Ge Shen, Min Chang, Tingting Jiang, Wen Deng, Huihui Lu, Fangfang Sun, Yao Lu, Yuanjiao Gao, Ruyu Liu, Mengjiao Xu, Xiaoxue Chen, Leiping Hu, Lu Zhang, Minghui Li, Yao Xie
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
AimsComparison of liver histopathological findings to explore the occurrence of liver inflammation in patients with chronic hepatitis B (CHB) under different alanine aminotransferase (ALT) normal values.MethodsThe patients who were diagnosed as chron
Externí odkaz:
https://doaj.org/article/0d6aec048dfa4da9b8c16c7f226949f6
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
International Journal of Molecular Sciences, Vol 22, Iss 20, p 11227 (2021)
Chronic hepatitis B (CHB) is an infectious viral disease that is prevalent worldwide. Traditional nucleoside analogues, as well as the novel drug targets against hepatitis B virus (HBV), are associated with certain critical factors that influence the
Externí odkaz:
https://doaj.org/article/d9995cd521314afca43f3cde03ee34e1
Autor:
Pérez-Latorre, Leire, Berenguer, Juan, Micán, Rafael, Montero, Marta, Cifuentes, Carmen, Puig, Teresa, Sanz, José, Ferrero, Oscar L, De La Fuente, Belén, Rodríguez, Carmen, Reus, Sergio, Hernández-Quero, José, Gaspar, Gabriel, Pérez-Martínez, Laura, García, Coral, Force, Luis, Veloso, Sergio, De Miguel, Marta, Jarrin-Vera, Inmaculada, González-García, Juan, GeSIDA 8514 Study Group
Publikováno v:
Repisalud
Instituto de Salud Carlos III (ISCIII)
Eurosurveillance
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante
Instituto de Salud Carlos III (ISCIII)
Eurosurveillance
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante
Background Recent and reliable estimates on the prevalence of coinfection with human immunodeficiency virus (HIV) and hepatitis B virus (HBV) in Europe are lacking. Aim Leveraged on a study designed to assess HIV/HCV coinfection prevalence, we assess
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Giuseppina Brancaccio, Milensu Shanyinde, Massimo Puoti, Giovanni B. Gaeta, Antonella D’ARMINIO Monforte, Alessandra Vergori, Stefano Rusconi, Antonio Mazzarelli, Antonella Castagna, Andrea Antinori, Alessandro Cozzi-Lepri
Publikováno v:
Pathog Glob Health
Hepatitis Delta virus (HDV) causes severe liver disease. Due to similarities in transmission routes, persons living with HIV (PLWH) are at risk of HDV infection. This analysis investigates the prevalence and the long-term clinical outcome of people w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a774c6919d4c4f0ec49c917db8b3adc0
http://hdl.handle.net/11577/3421445
http://hdl.handle.net/11577/3421445
Publikováno v:
Viruses, Vol 2, Iss 6, Pp 1279-1305 (2010)
While 25 compounds have been formally licensed for the treatment of HIV infection (AIDS), only seven licensed products are currently available for the treatment of chronic hepatitis B virus (HBV) infection: interferon-α, pegylated interferon-α, lam
Externí odkaz:
https://doaj.org/article/a6498fc1b8444932a19b633d00c8433f
Publikováno v:
Diseases, Vol 6, Iss 2, p 27 (2018)
Since the discovery of the hepatitis B virus (HBV) by Blumberg et al. in 1965, its genome, sequence, epidemiology, and hepatocarcinogenesis have been elucidated. Globally, hepatitis B virus (HBV) is still responsible for the majority of hepatocellula
Externí odkaz:
https://doaj.org/article/97e3929ee9b844018218dde6abf5041a
Autor:
Cheng-Han Lee, Yung-Liang Wan, Tse-Hwa Hsu, Shiu-Feng Huang, Ming-Chin Yu, Wei-Chen Lee, Po-Hsiang Tsui, Yi-Cheng Chen, Chun-Yen Lin, Dar-In Tai
Publikováno v:
Applied Sciences, Vol 7, Iss 11, p 1164 (2017)
Inflammation has significant impacts on liver fibrosis measurement by ultrasound elastography. The interpretation requires further optimization in patients with or without anti-viral therapy. We prospectively enrolled a consecutive series of patients
Externí odkaz:
https://doaj.org/article/4b30de83069a4c6f94dce0a942209d63